Excess cancer mortality in psychiatric patients

Canadian Journal of Psychiatry

Volumn 53, Issue 11, 2008, Pages 753-761

  Kisely, Stephen ^a   Sadek, Joseph ^b   MacKenzie, Adrian ^b   Lawrence, David ^c   Campbell, Leslie Anne ^d  

^a GRIFFITH UNIVERSITY   (Australia)

^b DALHOUSIE UNIVERSITY   (Canada)

^c CURTIN UNIVERSITY   (Australia)

^d Capital Health District   (Canada)

Author keywords

Cancer incidence; Mortality; Psychiatric disorder

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANADA; CANCER INCIDENCE; CANCER MORTALITY; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MENTAL DISEASE; MENTAL PATIENT; PROSTATE CANCER; RISK FACTOR;

EID: 56449091337     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805301107     Document Type: Article

References (40)

1. Black DW, Winokur G. Cancer mortality in psychiatric patients: the Iowa record-linkage study. Int J Psychiatry Med. 1986;16:189-197.
2. Casadebaig F, Quemada N. Mortality in psychiatric inpatients. Acta Psychiatrica Scand. 1989;79:257-264.
3. Saku M, Tokudome S, Ikeda M, et al. Mortality in psychiatric patients, with a specific focus on cancer mortality associated with schizophrenia. Int J Epidemiol. 1995;24:366-372.
4. Lichtermann D, Ekelund J, Pukkala E, et al. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry. 2001;58:573-578.
5. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-217.
6. Barak Y, Achiron A, Mandel M, et al. Reduced cancer incidence among patients with schizophrenia. Cancer. 2005;104(12):2817-2821.
7. Cohen M, Dembling B, Schorling J. The association between schizophrenia and cancer: a population-based mortality study. Schizophr Res. 2002;57:139-146.
8. Dalton SO, Mellemkjaer L, Thomassen L, et al. Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993. Schizophr Res. 2005;75:315-324.
9. Mortensen PB. The occurrence of cancer in first admitted schizophrenic patients. Schizophr Res. 1994;12:185-194.
10. Grinshpoon A, Barchana M, Ponizovsky A, et al. Cancer in schizophrenia: is the risk higher or lower? Schizophr Res. 2005;73:333-341.
11. Gulbinat W, Dupont A, Jablensky A, et al. Cancer incidence of schizophrenia patients: results of record linkage studies in three countries. Br J Psychiatry Suppl. 1992;18:75-83.
12. Masterson E, O'Shea B. Smoking and malignancy in schizophrenia. Br J Psychiatry. 1984;145:429-432.
13. Hippisley-Cox J, Vinogradova Y, Coupland C, et al. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry. 2007;64:1368-1376.
14. Yovel G, Sirota P, Mazeh D, et al. Higher natural killer cell activity in schizophrenic patients: the impact of serum factors, medication, and smoking. Brain Behav Immun. 2000;14:153-169.
15. Carrillo JA, Benitez J. Are antipsychotic drugs potentially chemo-preventive agents for cancer? Eur J Clin Pharmacol. 1999;55:487-488.
16. Cohen Y, Chetrit A, Cohen Y, et al. Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment. Med Oncol. 1997;15:32-36.
17. Lawrence D, Jablensky AV, Holman CD, et al. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatrica Scand. 2000;101:382-388.
18. Kisely S, Smith M, Lawrence D, et al. Mortality in individuals who have had psychiatric treatment in Nova Scotia. Br J Psychiatry. 2005;187:552-558.
19. Lawrence D, Jablensky AV, Holman CD. Preventable physical illness in people with mental illness. Perth (AUS): University of Western Australia; 2001.
20. Population Health Research Unit. Research data repository [Internet]. Halifax (NS): Dalhousie University; 2007 [cited 2008 Aug 1]. Available from: http://metadata.phru.dal.ca/.
21. Gilbert C. Mental health surveillance. Proceedings of the Mental Health Research Showcase, 2006 Oct 30-Nov 1, Banff (AB) [Internet]. Edmonton (AB): Mental Health Board; 2006 [cited 2008 Aug 1]. Available from: http://www.buksa.com/showcase/archive06/docs/020D-Gilbert.pdf.
22. Gilbert C, Jones W, Schopflocher D, et al. Use of provincial administrative data for surveillance of mental disorders, feasibility study. Ottawa (ON): Surveillance Division, Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada; 2008.
23. National Diabetes Surveillance System. Responding to the challenge of diabetes in Canada. First report of the National Diabetes Surveillance System [Internet]. Ottawa (ON): Health Canada; 2003 [cited 2008 Aug 1]. Available from: http://www.phac-aspc.gc.ca/ccdpc-cpcmc/ndss-snsd/english/pubs_reports/pdf/ WEB_NDSS_English_Report-nocover.pdf.
24. Ontario Hospital Association, Ontario Ministry of Health Hospital Medical Records Institute. Report of the Ontario Data Quality Reabstracting Study. Toronto (ON): Ontario Hospital Association; 1991.
25. Williams JI, Young W. Inventory of studies on the accuracy of Canadian health administrative databases. Pub no 96-03-TR. Toronto (ON): Institute for Clinical Evaluative Sciences; 1996.
26. Kisely S, Campbell LA, Crossman D, et al. Are the health of the nation outcome scales a valid and practical instrument to measure outcomes in North America? A three-site evaluation across Nova Scotia. Community Ment Health J. 2007;43:91-107. Epub 2006 Oct 5.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Arlington (VA): APA; 1994.
28. Cancer Care Nova Scotia. Cancer Surveillance and Epidemiology Unit [Internet]. Halifax (NS): Cancer Care Nova Scotia; 2006 [cited 2008 Aug 1]. Available from: http://www.cancercare.ns.ca/inside.asp?cmPageID=134.
29. Rothman KJ. Modern epidemiology. Boston (MA): Little, Brown and Company; 1986.
30. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
31. Statistics Canada. Canada's population [Internet]. Ottawa (ON): Statistics Canada; 2006 [cited 2008 Aug 1]. Available from: http://www.statcan. ca/Daily/English/ 060927/d060927a.htm.
32. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer. 2002;94:2719-2727.
33. Hjerl K, Andersen EW, Keiding N, et al. Depression as a prognostic factor for breast cancer mortality. Psychosomatics. 2003;44:24-30.
34. Brown KW, Levy AR, Rosberger Z, et al. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med. 2003;65:636-643.
35. Levav I, Lipshitz, I, Novikov I, et al. Cancer risk among parents and siblings of patients with schizophrenia. Br J Psychiatry. 2007;190:156-161.
36. Osborn D, Levy G, Nazareth I, et al. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry. 2007;64:242-249.
37. Crisanti AS, Love EJ. Mortality among involuntarily admitted psychiatric patients, a survival analysis. Soc Psychiatry Psychiatr Epidemiol. 1999;34:627-633.
38. Paszat LF, Mackillop WJ, Groome PA, et al. Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med. 1998;21:125-134.
39. Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19:137-144.
40. Reynolds P, Hurley S, Torres M, et al. Use of coping strategies and breast cancer survival, results from the black/white cancer survival study. Am J Epidemiol. 2000;152:940-949.